InfuSystem Holdings (INFU) FCF Margin (2010 - 2026)
InfuSystem Holdings (INFU) posted FCF Margin of 2.41% for Q1 2026, down 80.39% on a QoQ basis from 12.31% in Q4 2025, and down 481.0% year-over-year from 0.63% in Q1 2025.
InfuSystem Holdings (INFU) FCF Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings' FCF Margin history runs 17 years deep, the most recent figure standing at 2.41% for Q1 2026.
- Quarterly FCF Margin fell 481.0% year-over-year to 2.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.78% (down 379.0% YoY) and the FY2025 annual result came in at 14.86%, down 176.0% from the prior year.
- FCF Margin was 2.41% for Q1 2026 at InfuSystem Holdings, down from 12.31% in the prior quarter.
- Across five years, FCF Margin topped out at 32.55% in Q3 2024 and bottomed at 1.54% in Q1 2023.
- A 5-year average of 12.82% and a median of 11.22% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin plunged 1663 bps — and 2024, when it soared 2486 bps.
- InfuSystem Holdings' FCF Margin stood at 11.22% in 2022, then soared by 88 bps to 21.13% in 2023, then increased by 22 bps to 25.84% in 2024, then sank by 52 bps to 12.31% in 2025, then plunged by 80 bps to 2.41% in 2026.
- Business Quant data shows INFU's FCF Margin at 2.41% in Q1 2026, 12.31% in Q4 2025, and 23.06% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 2.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41% |
| Dec 31, 2025 | 12.31% |
| Sep 30, 2025 | 23.06% |
| Jun 30, 2025 | 16.48% |
| Mar 31, 2025 | 7.23% |
| Dec 31, 2024 | 25.84% |
| Sep 30, 2024 | 32.55% |
| Jun 30, 2024 | 4.20% |
| Mar 31, 2024 | 2.35% |
| Dec 31, 2023 | 21.13% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 7.17% |
| Mar 31, 2023 | -1.54% |
| Dec 31, 2022 | 11.22% |
| Sep 30, 2022 | 10.65% |
| Jun 30, 2022 | 20.11% |
| Mar 31, 2022 | 15.08% |
| Dec 31, 2021 | 10.68% |
| Sep 30, 2021 | 22.67% |
| Jun 30, 2021 | 23.63% |